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Available online 18 October 2016The degradation of histamine catalyzed by the SAM-dependent histamine N-methyltransferase (HNMT) is
critically important for the maintenance of neurological processes. Recently, two mutations in the encoding
human genewere reported to give rise to dysfunctional protein variants (G60D and L208P) leading to intellectual
disability. In the present study, we have expressed eight L208 variants with either apolar (L208F and L208V),
polar (L208N and L208T) or charged (L208D, L208H, L208K and L208R) amino acids to deﬁne the impact of
side chain variations on protein structure and function. We found that the variants L208N, L208T, L208D and
L208H were severely compromised in their stability. The other four variants were obtained in lower amounts
in the order wild-type HNMT N L208F = L208 V N L208 K = L208R. Biochemical characterization of the two
variants L208F and L208V exhibited similar Michaelis-Menten parameters for SAM and histamine while the
enzymatic activity was reduced to 21% and 48%, respectively. A substantial loss of enzymatic activity and binding
afﬁnity for histamine was seen for the L208K and L208R variants. Similarly the thermal stability for the latter
variants was reduced by 8 and 13 °C, respectively. These ﬁndings demonstrate that position 208 is extremely
sensitive to side chain variations and even conservative replacements affect enzymatic function. Molecular
dynamics simulations showed that amino acid replacements in position 208 perturb the helical character and dis-
rupt interactionswith the adjacentβ-strand, which is involved in the binding and correct positioning of histamine.
This ﬁnding rationalizes the gradual loss of enzymatic activity observed in the L208 variants.







Histamine, [2-(1H-imidazol-4-yl)ethanamine], is a biogenic amine
that plays important roles in several physiological and pathological pro-
cesses including the regulation of inﬂammatory and immune responses,
gastric acid secretion and bronchial asthma [1–4]. Histamine also func-
tions as a neurotransmitter in the central nervous system (CNS) where
it contributes to the regulation of many processes such as the sleep/
wake cycle, the circadian rhythm, thermoregulation, stress and ﬂuid
homeostasis [5–7]. Furthermore, histamine acts as a key neuromodulator
in the developing nervous system. In the embryonic state of the develop-
ing rat brain the maximum level of histamine concentration coincides
with the period where neuronal differentiation takes place in several
brain regions [8–10]. Histidine decarboxylase, a pyridoxal 5′-phosphate
(PLP)-dependent enzyme, catalyzes the decarboxylation of the aminoine oxidase; HNMT, histamine
-adenosylmethionine; SAH, S-
roux).
. This is an open access article underacid L-histidine to generate histamine, which is stored in granules
in airway mast cells, basophils and enterochromafﬁne cells [5,11].
Release of histamine from cells is triggered upon the cross-linking
surface-bound immunoglobulin E (IgE) by allergens [12]. The actions of
released histamine are mediated through the four histamine receptors
(H1R\\H4R), which belong to the rhodopsin-like family of G protein-
coupled receptors [13–15]. H1R, H2R and H3R are expressed in abun-
dance in the brain whereas H4R is expressed mainly in peripheral
tissues (e.g. the gut and connective tissue) [14,16]. Released histamine
is then rapidly inactivated and disappears from the bloodstreamwithin
minutes [5].
In mammals, the action of histamine is terminated by either one of
two mechanisms that involve the methylation of the imidazole ring or
the oxidative deamination of the primary amino group. The former
reaction is catalyzed by histamine N-methyltransferase (HNMT; EC
2.1.1.8) and the latter reaction by diamine oxidase (DAO; EC 1.4.3.22)
[17]. Products generated from these two enzymatic reactions are
virtually inactive at histamine receptors and are further converted for
transport and secretion [18,19]. HNMT is the primary metabolizing en-
zyme for released histamine in bronchial epithelial cells, endothelial
cells of human airways and the human stomach [20,21]. In addition,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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histamine action in the mammalian brain, since the other histamine-
metabolizing enzyme, DAO, is not expressed in the CNS [5,22]. DAO,
an enzyme of the class of copper-containing amine oxidases, is the
main histamine-degrading enzyme in peripheral tissue including termi-
nation of exogenous histamine from ingestion (food and alcohol) [14].
HNMT inactivates histamine by transferring a methyl group from
S-adenosylmethionine (SAM), to the Nε2 atom of the imidazole ring,
generating N-methylhistamine and S-adenosylhomocysteine (SAH)
[23,24]. Enzyme activity and mRNA transcription were found in most
human tissues with the highest levels in kidney and liver as well as
substantial levels observed in spleen, prostate, ovary, intestine and the
spinal cord and lower levels in the heart, brain, placenta, lung, stomach
and thyroid gland [18,25]. The HNMT gene is approximately 34 kb
in length, located on chromosome 2q22.1, and consists of 6 exons
[26–28]. Production and characterization of human HNMT showed
that cytoplasmic HNMT has 292 amino acid residues with a totalmolec-
ular mass of 33 kDa [18]. Several three-dimensional structures of HNMT
with bound SAH and histamine as well as various HNMT inhibitors re-
vealed that HNMT is a monomeric protein and consists of two domains.
The large domain adopts a canonical methyltransferase (MTase) fold
with a SAM binding pocket, whereas the small domain contributes
part of the histamine binding pocket and may be involved in protein-
protein interactions. The bound histamine is buried in a hydrophobic
pocket (surrounded by 14 aromatic amino acid residues) at the
interface of the two domains. Amino acid residues that interact with
SAH and histamine are highly conserved in vertebrates [29,30].
Since disturbances of histamine metabolism have been related to
several diseases, i.e. asthma, bronchial hyper-responsiveness (BHR),
neurological disorders, the lack of transcription or decrease in HNMT
activity have been proposed as a causative factor for these diseases. A
common single nucleotide polymorphism (SNP), c.314CNT transition
(prevalence 0.1), resulting in the replacement of T105 for isoleucine
was associated with decreased enzyme activity, immunoreactive pro-
tein, and thermal stability [25]. Steady-state kinetics revealed that the
apparent Michaelis constants (KM) increased 1.8 and 1.3 fold for SAM
and histamine, respectively, and showed a reduction of the speciﬁc
activity of about 16% [29]. Moreover, from multiple molecular dynamic
(MD) simulations, isoleucine 105 apparently more strongly interacts
with neighboring residues leading to a disordering of several key
residues responsible for SAM binding and lower hydrophobicity of the
substrate-binding site [31]. Thus, the polymorphic T105I variant has
been proposed to associate with several diseases including asthma,
allergic rhinitis, essential tremor and Parkinson's disease [32–35].
Intellectual disability (ID) is a common neurodevelopmental
disorder characterized by an intelligence quotient of 70 or below with
deﬁcits in adaptive, daily living skills and intellectual functioning
manifesting before the age of 18 [36]. With a prevalence of about 1%
of children worldwide, ID is one of the major socioeconomic problems
[37]. Recently, two other homozygous missense mutations in the
HNMT gene were identiﬁed in patients affected with nonsyndromic
autosomal recessive intellectual disability (ND-ARID) from two unrelated
consanguineous families of Turkish and Kurdish ancestry [38]. The ﬁrst
mutation (HNMT c.179GNA) from the Turkish family resulting in a
change of G60 to aspartate (G60D) occurs in the conservedMTase region
I, which is part of the SAM-binding pocket. This amino acid exchange
impedes binding of SAM as shown in our previouswork [38]. As a conse-
quence, the G60D variant does not show any activity in the methylation
of histamine and thus the pathway of histamine inactivation is blocked.
The other mutation (HNMT c.632TNC) found in the Kurdish family
results in the replacement of L208 for proline (L208P). This invariant
residue is located in helix E of the MTase domain and forms several
hydrophobic interactions with neighboring residues. Interestingly, L208
is located in a considerable distance from the active site (ca. 18 Å from
the substrate binding pocket) (Fig. 1, panels A-C) suggesting that the
adverse effect of the amino acid replacement is caused by perturbationsof the protein structure leading to compromised enzyme function. In
fact, previous attempts to express the L208P variant were not successful
[38]. In order to better understand the role and importance of L208 in
maintaining protein structure, stability and enzyme function we have
engaged in a more detailed analysis by generating a series of variants
with either apolar (L208V and L208F), polar (L208T and L208N) or
charged (L208R, L208K, L208H, and L208D) amino acid replacements.
In the present studywe report the biochemical properties of the variants
that were successfully expressed. In addition, we have investigated the
role of L208 and the impact of variations in this position by a set of
molecular dynamic simulations. Taken together these methods have
provided detailed insights into the functional and structural role of
L208 and provide a rationale for the disease causing effect of mutations
affecting this amino acid position.
2. Materials and methods
2.1. Reagents
All chemicals and reagents were of the highest purity commercially
available from Sigma-Aldrich, Merck, and Carl Roth GmbH & Co. KG.
[Methyl-3H]-SAM and Ultima Gold liquid scintillation cocktail were
from PerkinElmer. Ni-Sepharose (prepacked HisTrap™ HP) and
Superdex 200 prep grade (HiLoad 16/600 Superdex 200 pg) columns
were from GE Healthcare (Little Chalfont, UK). HNMT (wild-type) and
L208 variantswere overexpressed in Escherichia coli and puriﬁed as pre-
viously described [38]. The concentrations of the following compounds
were determined spectrophotometrically using the respective extinc-
tion coefﬁcients: SAM and SAH, ε260 = 15.4 mM−1 cm−1 [39]; and
HNMT (wild-type and L208 variants, based on amino acid sequence),
ε280 = 42.8 mM−1 cm−1.
2.2. Site-directed mutagenesis
Site-directed mutagenesis at position L208 was performed using
QuickChange® Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA, USA). The mutagenic forward primers and the reverse primers
(Supplemental Table S1) were from VBC-Biotech Service GmbH
(Vienna, Austria). The plasmid pET-21a harboring HNMT (wild-type)
gene was used as the template for mutagenic PCR. PCR reactions
(18 cycles of the standardized protocol) were performed using a
PCR instrument with GeneAmp PCR system, Applied Biosystem®
(Thermo Fisher Scientiﬁc, Waltham, MA, USA). The DNA sequences
of all variant plasmids were analyzed using the forward primers 5′-
TAATACGACTCACTATAGGG-3′ (T7-Promoter) and the reverse primer
5′-GCTAGTTATTGCTCAGCGG-3′ (T7-terminator) by LGC Genomics
(Teddington, UK).
2.3. Protein production and puriﬁcation of HNMT (wild-type) and L208
variants in Escherichia coli
Protein production and puriﬁcation of HNMT (wild-type) and L208
variants (L208V, L208F, L208T, L208N, L208R, L208K, L208H, and
L208D) with C-terminal His6 tag in Escherichia coli was performed:
E. coli BL21 (DE3) was transformed with the plasmid pET-21a harboring
HNMT (wild-type ormutated L208) genes. A colony of the transformants
was inoculated in lysogen broth (LB) containing 100 μg/mL of ampicillin
to prepare a preculture, which was aerobically incubated at 37 °C and
150 rpm for 16 h. The precultured cells (1% of cell inoculation) were
transferred to 10 L of LB containing 100 μg/mL of ampicillin. Cells were
grown at 37 °C and 150 rpm until the absorption at 600 nm of the cell
culture reached ~1.0. Synthesis of the recombinant protein was induced
by adding 0.1 mM of isopropyl β-D-thiogalactopyranoside (IPTG).
The cell culture was further grown at 18 °C and 150 rpm for 16 h. Cells
were harvested using centrifugation at 5000 g for 10 min. Cell paste
was kept at−70 °C until used.
Fig. 1. Structure of HNMTwith a focus on position 208, sequence alignment and protein stability analysis. Cartoon of HNMT variant structures depicting sections of the hydrophobic
pockets around residue 208 for L208 (wild-type) in yellow (A) and L208P in orange (B)with surrounding apolar residues: I170, Y215, I288, and I290 in purple and L155, L204, L211, G212,
L213 in light blue. (C) Protein sequence alignment of HNMT homologs using Clustal Omega 1.2.1 (www.clustal.org/omega) at the hydrophobic pocket surrounding residue L208. The L208 is
highlighted inyellow. Residues I170, Y215, I288, and I290were highlighted in purple and residues L155, L204, L211, G212, L213 in lightblue. AllHNMT sequences used for thealignmentwere
obtained from NCBI Reference Sequence Database: human (NP_008826.1), chimpanzee (XP_001156140.1), gorilla (XP_004032652.1), bovine (NP_001030511.1), pig (NP_001166431.1),
mouse (NP_536710.1), chicken (NP_001264802.1), xenopus (NP_001080614.1), opossum (UniProtKB browser_F6X9A6), zebraﬁsh (NP_001003636.1), and tetraodon (Q4SB6.1).
(D) Effect of amino acid substitutions at position 208 on protein stability as calculated by SNPeffect 4.0 (FoldX) expressed as the difference to wild-type protein (ΔΔG in kcal/mol).
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the wild-type or L208 variants was thawed and resuspended in lysis
buffer using 2.5 mL of buffer/g of cell paste. This buffer contained
50 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM imidazole, 1 mM DTT,
100 μM PMSF and supplemented with protease inhibitors (Roche
complete EDTA-free protease inhibitor cocktail, Roche). Cells were
disrupted using ultrasonication with 50% amplitude for 15 min.
Cell debris and unbroken cells were removed from the cell lysate to
gain the clear crude extract using centrifugation at 40,000 g and 4 °C
for 1 h. The clear crude extract was ﬁltrated (0.45 μm) and then applied
onto a 5-mL Ni-Sepharose HisTrap™ HP column (GE-Healthcare, Little
Chalfont, UK) previously equilibrated with 50 mM Tris-HCl pH 8.0,
300 mM NaCl and 10 mM imidazole. The column was washed with
50 mM Tris-HCl buffer pH 8.0 containing 300 mM NaCl and 20 mM
imidazole. HNMT was eluted using 50 mM Tris-HCl buffer, pH 8.0
containing 300 mM NaCl and 300 mM imidazole. Eluted fractions
containing HNMTwere pooled, and then concentrated using a Centricon
YM10 with 10 kDa cut-off. The concentrated protein fraction was
loaded onto a Superdex 200 prep grade column (HiLoad 16/600
Superdex 200 pg, GE-Healthcare, Little Chalfont, UK) previously
equilibrated with 50 mM Tris-HCl pH 8.0 containing 100 mM
NaCl. HNMT fractions were pooled and then concentrated as described
before. The puriﬁed HNMTwas ﬂash frozen in liquid nitrogen and stored
at −70 °C until used. To check protein purity and subunit molecular
mass of HNMT, aliquots of the protein fractions were analyzed using
12.5% SDS-PAGE and staining with Coomassie Brilliant Blue R250.
Catalytic activity for histamine N-methyltransferase of the protein
fractions was determined using a radioactive methylation assay as
described below.2.4. Western blotting
Protein samples for western blot analysis were separated using 12.5%
SDS-PAGE and then electrically transferred to a nitrocellulose membrane
by applying electricity (150 mA) from a power supply for 1 h. The mem-
brane was blocked for 1 h using 13% milk powder in TBS buffer (50 mM
Tris-HCl buffer pH 8.0 and 150 mMNaCl) containing 0.1% tween-20. The
membrane was incubated with the primary rabbit His-Tag antibody
(1:1000 dilution, Cell Signaling Technology®, Danvers, MA, USA) for
16 h, and then incubated with the secondary antibody anti-rabbit IgG,
horseradish peroxidase-linked antibody (1:5000 dilution, Cell Signaling
Technology®, Danvers, MA, USA) for 1 h. To detect chemiluminescent
signal of antibody-bound His6 tagged HNMT, the immunoblots were de-
veloped using enhanced chemiluminescent western blotting substrate
solution (Pierce-Thermo Fisher Scientiﬁc, Waltham, MA, USA).
2.5. Determination of melting temperature of HNMT (wild-type) and L208
variants
To investigate the thermal stability of HNMT (wild-type) and L208
variants in the absence and presence of substrates, SAM and histamine,
themelting temperaturewas determined by a ﬂuorescence-based ther-
mal shift assay, using SYPRO Orange (Sigma-Aldrich, St. Louis, MO,
USA). Experiments were performed in a CFX Connect™ real-time PCR
detection system (Bio-Rad, Hercules, CA, USA) with a 96-well plate in
FRET scan mode. To prepare protein samples for the measurement,
5 μL of 1 mg/mL HNMT (wild-type or L208 variants) were mixed with
5 μL of SYPRO Orange solution (200-fold dilution) and 15 μL of a buffer
containing 50mMTris-HCl pH 8.0 and 100mMNaCl to a ﬁnal volume of
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(SAM or histamine) were prepared similarly as described above but
either SAM or histamine was added to a ﬁnal concentration of 2 mM.
A temperature gradient from 20 °C to 95 °C was set to monitor thermal
unfolding of the protein, measuring ﬂuorescence emission at 0.5 °C
increments with a 60 s hold for signal stabilization. The melting temper-
ature of the protein in the absence and presence of substrates was
obtained from the peak of the derivatives of the experimental data.
2.6. Determination of dissociation constants (Kd) of HNMT (wild-type) and
L208 variants
All of the experiments to investigate dissociation constants (Kd) for
SAM, SAH, and histamine to HNMT (wild-type) and L208 variants and
for histamine to the binary complex of HNMT:SAH were performed
using a VP-ITC system (MicroCal, Northampton, MA, USA) in 50 mM
Tris-HCl buffer pH 8.0 containing 100 mM NaCl at 25 °C. All solutions
were degassed before measurements. The HNMT (wild-type) solution
(30 μM) was injected with SAM (0.42 mM), SAH (0.38 mM), or
histamine (4 mM) (20 injections, 15 μL/injection, duration time 29.9 s,
spacing time 250 s). Titration experiments for SAM, SAH and histamine
binding to the L208V and L208F variants were set to 20 injections of
15 μL of 0.7 mM SAM, 0.55 mM SAH, or 4 mM histamine, respectively,
(duration time 29.9 s, spacing time 250 s) into the cell containing
30 μM HNMT (L208V and L208F). To determine the Kd of L208R and
L208K variants for SAM, SAH, and histamine, 20 μM of the HNMT
proteins were titrated with SAM (1mM), SAH (0.8 mM), or 4 mM hista-
mine (20 injections, 15 μL/injection, duration time 29.9 s, spacing time
250 s). For the determination of the dissociation constants for histamine
to the binaryHNMT (wild-type, L208V, and L208K):SAH complex (20 μM
HNMT:120–250 μM SAH), histamine (0.58 mM for HNMT (wild-type)
and 0.50 mM for the L208 variants) was titrated into the complex solu-
tion (20 injections, 15 μL/injection, duration time 29.9 s, spacing time
250 s). The Kd values of HNMT (wild-type) and L208 variants for SAM,
SAH, histamine, and histamine in the presence of SAH were obtained
ﬁtting the data to a single-binding-site model with Origin version 7.0
(MicroCal, Northampton, MA, USA) for ITC data analysis.
2.7. Determination of catalytic activity of HNMT (wild-type) and L208
variants
To measure catalytic activity of HNMT (wild-type) and L208
variants; L208V, L208F, L208R, and L208 K, radioactive methylationFig. 2. Protein production and puriﬁcation for HNMT (wild-type) and L208 variants. The rec
Ni-Sepharose afﬁnity and Superdex 200 size-exclusion chromatography. SDS-PAGE (12.5%) an
L208K (F) after each step of the protein puriﬁcation. Each lane was loaded with either 20 (w
molecular mass protein marker; lane 1, crude extract; lane 2, the protein fraction after Ni-Se
chromatography.assays were performed at 25 °C. [Methyl-3H]-SAM was utilized and
the methylation reaction was monitored by formation of the product,
[methyl-3H]-histamine [29,40,41]. The assay reaction in a 1.5 mL
Eppendorf tube contained 20 nM HNMT (wild-type or L208 variants),
40 μM unlabeled SAM, 40 μM histamine, 0.158 μCi [methyl-3H]-SAM,
1mMEDTA, and 0.025% bovine serum albumin in 125mMbicine buffer
pH 8.0 to make up a ﬁnal volume of 100 μL. The reaction mixture was
preincubated at 25 °C for 2 min prior to the addition of histamine to
initiate the reaction. The termination of the reaction was conducted by
adding 75 μL of 1M sodiumborate pH11 after the reactionwas incubated
at 25 °C for 30 min. The product, [methyl-3H]-histamine, was isolated
from unincorporated [methyl-3H]-SAM in the reaction by organic
extraction by adding 1:1 toluene:isoamyl alcohol (1.25 mL). After
vortexing and centrifugation at 21,100 g for 1 min, 1 mL of the organic
phase was transferred to a 1.5 mL Eppendorf tube and then mixed with
250 μL of 0.5 M HCl. The tube was again vortexed and centrifuged to
facilitate phase separation. 200 μL of the aqueous phase were transferred
to a scintillation vial containing 10 mL of Ultima Gold liquid scintillation
cocktail (PerkinElmer, Waltham, MA, USA). After mixing, the vial was
quantiﬁed by scintillation spectrometry. To determine the variant's and
wild-type enzymes' kinetic parameters, KM and kcat, for SAM, histamine
was ﬁxed at saturating concentration of 40 μM and the concentration of
SAMwas varied in the range of 5–80 μM. In order to obtain the respective
kinetic parameters for histamine, the SAM concentration was kept
constant at 40 μM and histamine concentration was varied in the range
of 1–20 μM.Data analysis to obtain the kinetic parameterswas performed
by plotting the rate of [methyl-3H]-histamine formation normalized by
the HNMT concentration (v/e) versus the substrate concentration (SAM
or histamine) and ﬁtting the data points using Marquardt-Lavenberg
algorithms in the KaleidaGraph program (Synergy Software, Reading,
PA, USA). The data points shown in the plots represent the mean of two
independent measurements.
2.8. Measurements of circular dichroism (CD) spectrometry
To determine the secondary structure of HNMT (wild-type) and
L208 variants, circular dichroism (CD) spectrometry was performed
using a Jasco J715 spectropolarimeter (JASCO Inc., Tokyo, Japan)
equipped with thermostat cell compartments. The CD spectra of
HNMT in the far UV region (260–185 nm) were recorded in quartz
cells with path length 0.02 cm (Hellma, Forest Hills, NY, USA) with a
scan speed of 100 nm/min at 25 °C, averaged over three scans and
corrected by the blank signal. HNMT was prepared in 20 mMombinant HNMT (wild-type) and L208 variants were expressed in E.coli and puriﬁed using
alysis of HNMT (wild-type) (A) and L208 variants: L208V (B), L208F (C), L208R (D), and
ild-type, L208R and L208K variants) or 25 μg (L208V and L208F variants). Lane M, low
pharose chromatography; lane 3, the protein fraction after Superdex 200 size-exclusion
Table 1
Protein puriﬁcation table for HNMT (wild-type) and soluble L208 variants.
Step of protein puriﬁcation Wild-type L208V L208F L208R L208 K
total protein (mg) % yield total protein (mg) % yield total protein (mg) % yield total protein (mg) % yield total protein (mg) % yield
Crude extract 1727 100 1305 100 1307 100 1243 100 3852 100
Ni-Sepharose 197 11 64 5 68 5 42 3 43 1
Superdex 200 111 6 37 3 41 3 7 0.5 16 0.4
(6)a (2)a (2)a (0.2)a (0.4)a
Starting cell paste for protein puriﬁcation for HNMT (wild-type), L208 V, L208F, L208R, and L208K variants was 20, 19, 19, 30, and 45 g respectively.
a Amount of protein in mg per g of cell paste (mg/g) is shown in parentheses.
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0.6–1 mg/mL. The secondary structure content of HNMT (wild-type)
and L208 variants was analyzed using the Spectra Manager program
(JASCO Inc., Tokyo, Japan) and the web tool DichroWeb [42,43].Fig. 3. Binding of SAM to HNMT (wild-type) and L208 variants. ITC experiments were perfo
system (MicroCal). Isothermal calorimetric titrations of HNMT (wild-type) (A) and L208 v
dissociation constants for SAM binding to HNMT are indicated in panels A-E (see also Table 2)2.9. MALDI-TOF mass spectrometry
Protein extraction from polyacrylamide gels and MALDI-TOF mass
spectrometric measurements for HNMT (wild-type) and L208 variantsrmed in 50 mM Tris-HCl buffer, pH 8.0, containing 100 mM NaCl at 25 °C using a VP-ITC
ariants for L208V (B), L208F (C), L208R (D) and L208K (E) with SAM are shown. The
.
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bands on a polyacrylamide gel were excised and transferred to a 1.5 mL
Eppendorf tube. Each excised gel piece was washed with deionized
water prior to be vortexed in 10% acetic acid solution for 10 min. The
gel piece was consequently washed with deionized water followed by
acetonitrile and a ﬁnal washing step with deionized water. The stained
color of Coomassie Brilliant Blue R250 on each gel piece was removed
completely by incubating the gel in a destaining solution containing
formic acid:deionized water:isopropanol (1:3:2 v/v/v) for 30 min. The
gel piece was rinsed with deionized water and dehydrated with
acetronitrile. After the destaining procedure, cysteines in the gel piece
were alkylated and reduced by iodoacetamide and dithiothreitol (DTT),
respectively. Trypsin was then added to digest the protein in the gel at
37 °C overnight. After trypsin digestion, peptidemixtureswere extracted
and then desalted using ZipTip (Millipore, Darmstadt, Germany). The
desalted peptides were spotted onto a MALDI plate with a matrix con-
taining α-cyano-4-hydroxycinnamic acid. The mass spectra of peptides
were recorded using a Micromass Tof Spec 2E MALDI-TOF mass
spectrometer (Micromass, Cary, NC, USA) in reﬂectron mode at an
accelerating voltage of +20 kV. The instrument was calibrated with a
poly(ethylene glycol) mixture (Sigma-Aldrich, St. Louis, MO, USA).
ProteoMass™ ACTH Fragments 18–39 (Sigma-Aldrich, St Louis, MO,
USA) was used as the peptide calibration standard for the instrument.
To analyze mass spectra from the measurement, MassLynx 4.1 (Waters,
Milford, MA, USA) was utilized to assign peptide mass proﬁles.
2.10. In silico prediction of protein stability of the L208 variants
SNPeffect (version 4.0) (http://snpeffect.switchlab.org) [46,47] is a
web tool program, which is used to analyze the structural effect of
protein variations using various algorithms (TANGO, WALTZ, LIMBO,
and FoldX). Protein stability analysis and predicted protein structure
for L208 variants were determined and modelled by FoldX. The models
for L208 variants were created based on the HNMT wild-type crystal
structure (PDB: 1JQD, [29]). The calculation of the free-energy change
(ΔΔG) upon variations in the structural phenotype of the protein using
FoldX provides information of protein stability of the L208 variants.Fig. 4. Bindingof SAH toHNMT (wild-type) and L208 variants. ITC experimentswere perform
(MicroCal). Isothermal calorimetric titrations of HNMT (wild-type) (A) and L208 variants for
binding to HNMT (wild-type), L208V, and L208K are indicated in panels A-C (see also Table 2)In addition, theweb tool CUPSATwas utilized to analyze and predict pro-
tein stability upon substitution of L208 for other amino acids [48].
2.11. Molecular dynamics (MD) simulations of HNMT
The crystal structure of the T105 polymorphic variant of HNMT in
complex with S-adenosylhomocysteine (SAH) and histamine (PDB:1JQD,
chainB) [29]was used as a starting structure formolecular dynamic (MD)
simulations (This structure represents an enzyme-substrate complex at
pH 5.6, where the enzyme is inactive. An analogous structure at higher
pH, where the enzyme is active, was not available in the PDB database).
For calculations of HNMT in complex with the methylating cofactor
SAM and histamine, which represents the catalytically competent
enzymatic complex, a model was created based on the crystal structure.
Therefore, amethyl groupwas tethered to the sulfur atom to give a chiral
sulfur center in (S) conﬁguration,which constitutes the biologically active
form of SAM [49]. Variants of HNMT were produced by in silico point
mutations of the created HNMT model. MD simulations and analyses
were performed using the YASARA Structure suite, version 13.9.8
(YASARA Biosciences) [50]. A periodic simulation cell that enveloped
the whole enzyme with an additional 5 Å margin in each dimension,
was usedwith explicit solvent. TheAMBER03 forceﬁeld [51]was applied
and long-range electrostatic potentials were calculated using the Particle
Mesh Ewald (PME) method and a cutoff of 7.864 Å [52,53]. The
AutoSMILES utility was used to attribute force ﬁeld parameters to SAH
and histamine [54]. For SAMMulliken charges were generated by single
point DFT calculations via GAMESS [55], using the B3LYP/6-311G** basis
set.
Hydrogen bonding network optimizationswere carried out using the
method of Hooft and co-workers [56], and pKa values at pH 7.5 were
assigned [57]. The simulation cell was ﬁlled with water containing 0.9%
of NaCl and a density of 0.993 g/mL. Solvent was relaxed and the system
was subsequently energy minimized using steepest descent minimiza-
tion to remove conformational stress, followed by a simulated annealing
minimization step to convergence (b0.05 kJ/mol per 200 steps). Integra-
tion time steps were 1.33 and 4 fs for intra- and intermolecular forces,
respectively. Subsequently, MD simulations at 310 K were performed,ed in 50mMTris-HCl buffer pH8.0, containing 100mMNaCl at 25 °C using a VP-ITC system
L208V (B), and L208K (C) with SAH were presented. The dissociation constants for SAM
.
Table 2
Dissociation constants (Kd) of HNMT (wild-type) and L208 variants for SAM, SAH and
histamine in the presence of SAH by ITC.
HNMT Dissociation constants (Kd, μM)a
SAM SAH Histamine (in the presence of SAH)
Wild-type 49 ± 2 2 ± 0.2 19 ± 3
L208V 38 ± 2 6 ± 2 ND
L208F 42 ± 4 – –
L208R 62 ± 13 – –
L208K 64 ± 10 11 ± 3 ND
ND = not detectable and dash (−) = not measured.
a Three independent ITCmeasurementswere conducted for each L208 variant and ligand.
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forces of 1.25 fs and 2.5 fs were applied, respectively. All MD simulations
were carried out in quadruplicate with varying seed numbers and over a
time span of 25 ns.
3. Results
3.1. In silico prediction of protein stability
The three-dimensional structure of HNMT shows that the L208
residue is located in one of six helices, termed helix E, ﬂanking a
seven-stranded β-sheet of the MTase domain [29]. Although this
position is not in or near the active site of HNMT a multiple alignment
with vertebrate HNMTs (44–99% identity) revealed that L208 is invari-
ant indicating a conserved structural role of the residue (Fig. 1A and C).
In fact L208 has several contacts in the same and the neighboring
α-helix aswell as the adjacentβ-sheet (Fig. 1, panels A and B). Recently,
we have reported that in silico modeling revealed the drastic
destabilizing effect (ca. 8 kcal/mol) of the disease-related L208P variant
on its structural stability [38]. We concluded that this instability, which
correlates with the failure of the enzyme to be expressed as a soluble
protein, results in the pathology of the L208P variant. In this contextFig. 5. Binding of histamine to HNMT (wild-type) and L208 variants in the presence of S
(C) variants with histamine in the presence of SAH were performed in 50 mM Tris-HCl bu
experiment for HNMT (wild-type) consisted of 20 consecutive injections of histamine (0.58 m
For L208V and L208K, a solution of the L208 variants and 0.25 mM SAH in the cell was titrat
least-squares ﬁtting using Origin version 7.0 (Microcal) was conducted to obtain the dissocia
was no released heat observed after 20 consecutive injections of histamine into the L208 variawe would like to emphasize that it is difﬁcult to distinguish whether
an amino acid replacement blocks folding into the native topology or
destabilizes the native topology to such an extent that unfolding is
favored. In any case both scenario lead to the depopulation of the folded
state of a protein and as a consequence compromise its biological
function.
In order to assess further the importance of residue 208 for protein
stability we have extended our previous calculations using FoldX in
SNPeffect 4.0 [46,47]. As shown in Fig. 1D, all amino acid replacements
result in lower protein stability with the strongest effects found for
charged amino acids (Arg, Asp, Lys) whereas hydrophobic residues
were predicted to exert only a moderate effect on protein stability
(1–3 kcal/mol for L208F and L208 V). Results from calculations with
FoldX in SNPeffect 4.0 were consistent with protein stability changes
predicted by the web tool CUPSAT (data not shown). The analyses
conﬁrm that side chain packing in this hydrophobic pocket is critical
for the protein's structural stability. This insight prompted us to further
investigate protein stability and enzyme activity for the series of HNMT
variants displayed in Fig. 1D.
3.2. Protein production and puriﬁcation of L208 variants
Based on our in silico analysis for prediction of protein stability
(Fig. 1D) eight variations of human HNMT, i.e. L208V, L208F, L208T,
L208N, L208R, L208K, L208H, and L208D that covered the whole exper-
imental space in terms of predicted stability and amino acid properties
were chosen to be expressed in E.coli BL21 (DE3) cells as described in
Materials & Methods. The two variants with conservative amino acid
exchanges, i.e. L208V and L208F were expressed as soluble proteins. In
contrast, the variants L208T, L208N, L208H, and L208D were found
exclusively in inclusion bodies. Attempts to solubilize these variants
by coproduction with chaperones were not successful. Interestingly,
the two variants bearing a positively charged amino acid, i.e. L208R
and L208K, were also detectable as soluble proteins although the stabil-
ity prediction by FoldX has indicated a profound destabilizing effectAH. Isothermal calorimetric titrations of HNMT (wild-type) (A), L208V (B), and L208K
ffer pH 8, containing 100 mM NaCl at 25 °C using a VP-ITC system (MicroCal). The ITC
M, 15 μL/injection) into the cell containing 20 μM HNMT (wild-type) and 0.12 mM SAH.
ed with histamine (0.50 mM, 15 μL/injection, 20 injections). Data analysis by non-linear
tion constant for histamine binding to HNMT (wild-type) in the presence of SAH. There
nts in the presence of SAH.
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puriﬁed using a two-step protocol employing Ni-Sepharose afﬁnity
and size-exclusion chromatography (see Materials & Methods) as pre-
sented in Fig. 2. The yield of puriﬁed wild-type protein was 6 mg/g of
cell paste. A slightly lower yield of 2 mg/g wet cell paste was
achieved with the variants L208V and L208F whereas the yield for the
variants L208R and L208K were signiﬁcantly lower amounting to only
0.2–0.4 mg/g cell paste, respectively (Table 1).
3.3. Determination of dissociation constants using isothermal titration
calorimetry (ITC)
We have employed isothermal titration calorimetry (ITC) to deter-
mine the afﬁnity of SAM to wild-type HNMT and the soluble variants
L208V, L208F, L208R, and L208K. As shown in Fig. 3 (panels A–E),
titration of the proteinswith SAMat 25 °C produced exothermic signals.Fig. 6. Catalytic activity and steady-state kinetics of HNMT (wild-type) and L208
variants. (A) Percentage of enzymatic activity of HNMT (wild-type) and L208 variants.
(B) Michaelis-Menten plot for HNMT (wild-type) and L208 variant reactions when SAM
concentration was varied. Determination of HNMT activity using a radioactive
methylation assay was conducted at 25 °C, monitoring the product, methyl-histamine
[methyl-, 3H] formation. The reaction contained 20 nM HNMT (wild-type; ﬁlled circle,
L208V; empty circle, L208F; empty square, L208R; empty diamond, and L208K; empty
triangle) in 125 mM bicine buffer pH 8 with 0.15 μCi SAM [methyl-, 3H], 0.025% bovine
serum albumin, 1 mM EDTA, a ﬁxed concentration of histamine (40 μM), and various
concentrations of SAM (5, 10, 20, 40 and 80 μM). (C) Michaelis–Menten plot for HNMT
(wild-type) and L208 variant reactions when the histamine concentration was varied.
The HNMT activity was monitored at 25 °C from the reactions consisting of 20 nM
HNMT (wild-type; ﬁlled circle, L208V; empty circle, L208F; empty square, L208R; empty
diamond, and L208K; empty triangle) in 125 mM bicine buffer pH 8, 0.15 μCi SAM
[methyl-, 3H], 0.025% bovine serum albumin, 1 mM EDTA, a ﬁxed concentration of SAM
(40 μM), and various concentrations of histamine (1, 2, 5, 10 and 20 μM).The ITC titration datawere ﬁtted to a single-binding-sitemodel yielding
dissociation constants of 49 ± 2, 38 ± 2, 42 ± 4, 62 ± 13, and 64 ±
10 μM for the wild-type, L208V, L208F, L208R, and L208K, respectively.
The results indicate that afﬁnity of SAM to HNMT (wild-type) and
the L208 variants is not signiﬁcantly affected by the amino acid substi-
tution at position 208. Interestingly, the product SAH, binds twenty
times more tightly to the wild-type and six times more tightly to the
variants L208V and L208K than SAM, exhibiting dissociation constants
of 2 ± 0.2, 6 ± 2, and 11 ± 3 μM, respectively (Fig. 4 and Table 2).
In contrast to SAM and SAH, the binding of histamine to HNMT is not
detectable by ITC. However, in the presence of SAH, exothermal signals
were obtained upon titration with histamine enabling the determina-
tion of the dissociation constant by ﬁtting the data to a single-binding-
site model. This yielded a dissociation constant of 19 ± 3 μM (Fig. 5,
panel A). In the case of the L208V and L208K variants no signals were
obtained indicating that histamine binding is substantially affected
even in the conservative L208V variant (Fig. 5, panels B and C).
A summary of the data obtained by ITC is given in Table 2.
3.4. Catalytic activity of wild-type HNMT and the soluble L208 variants
To determine the effect of amino acid substitutions at position 208
on the catalytic activity, we employed a radioactive methylation assay
as described in Materials & Methods [29,40,41]. As shown in Fig. 6
(panel A), product formation (N-methylhistamine) was reduced to
48 ± 5%, 21 ± 2%, 6 ± 0.5% and 1 ± 0.05% for the L208V, L208F,
L208K and L208R variants, respectively, in comparison to the wild-
type enzyme. To gain further insight, a set of steady-state experiments
was performed at various concentrations of SAM and histamine. Kinetic
parameters of the methylation reaction were obtained by determining
the rate of [methyl-3H]-histamine generation as a function of SAM or
histamine concentrations (Fig. 6 B and C, respectively) and ﬁtting of
the data to the Michaelis-Menten equation. A summary of the kinetic
parameters is shown in Table 3. In the case of the L208V variant kinetic
parameters are onlymarginally affectedwith bothKM values in a similar
range as observed for the wild-type and a 3-times lower kcat. The L208F
variant is clearly more affected exhibiting signiﬁcantly higher KM values
and a 5.5-times lower kcat. This tendency is evenmore pronouncedwith
the L208R and L208K variants. In the case of the former variant no data
were obtained due to the low overall activity (see also Fig. 6, panel A).
3.5. Thermal stability of L208 variants of HNMT in the absence and presence
of SAM and histamine
The determination of thermal protein stability was performed by a
ﬂuorescence-based thermal shift assay (Thermoﬂuor® technique) to
obtain the melting temperatures (Tm) of wild-type and the soluble var-
iants (L208V, L208F, L208R, and L208K). This analysis was also carried
out in the presence of either SAM or histamine. A compilation of the
data is given in Table 4. In the case of the conservative replacements,
i.e. the L208V and L208F variants, only a slight decrease of the melting
temperature was observed. In contrast, the L208R and L208K variantsTable 3
Apparent kinetic parameters of HNMT reaction for HNMT (wild-type) and L208 variants.
HNMT KmSAM (μM) Kmhistamine (μM) kcat (s−1)
Wild-type 4.1 ± 1.2 1.9 ± 0.7 0.61 ± 0.08
L208V 6.8 ± 1.6 1.1 ± 0.2 0.23 ± 0.01
L208F 12.4 ± 4.8 3.4 ± 0.5 0.11 ± 0.01
L208R ND ND ND
L208 K 15.0 ± 5.8 ND 0.03 ± 0.006
ND = not detectable.
Enzymatic activity of HNMT was measured using radioactive methylation assay to deter-
mine the product formation ofmethyl-histamine [methyl-, 3H]. Two independentmethyl-
ation reactions were carried out for each L208 variant an substrate concentration
(p b 0.001, using a one-way ANOVA).
Table 4
Melting temperature (Tm, °C) of HNMT (wild-type) and L208 variants in the absence and
presence of SAM and histamine.
Substrate Melting temperature (°C)
Wild-type L208V L208F L208R L208 K
No substrate 61.3 ± 2.0* 57.8 ± 2.1* 60.4 ± 2.9NS 48.4 ± 0.6* 53.7 ± 1.8*
+SAM 61.5 ± 0.2* 58.9 ± 0.5* 59.4 ± 1.9* 51.7 ± 0.4* 53.4 ± 0.9*
+Histamine 60.4 ± 2.8* 56.9 ± 1.3* 59.8 ± 2.7 NS 48.3 ± 0.3* 51.5 ± 2.5*
At least six independent measurements were carried out for each l208 variant in the ab-
sence and presence of the substrates. The statistical signiﬁcance was calculated using
one-way ANOVA (* = p b 0.001; NS = not signiﬁcant, i.e. p = 0.169 and 0.113 for the
L208F variant in the absence and presence of histamine, respectively).
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8 °C, respectively. In the presence of either SAM or histamine no
signiﬁcant effects on the melting temperature were observed except
for a small thermal stabilization of the L208R variant in the presence
of SAM (Table 4). In summary, these results conﬁrm that position 208
plays an important role in maintaining the structural integrity of the
protein.
3.6. Determination of the secondary structure of L208 variants of HNMT
To determine the effect of amino acid substitutions on the secondary
structure and folding properties, circular dichroism spectra of HNMT
(wild-type) and the L208 variants (Supplemental Fig. S1) were record-
ed. Analysis of the CD spectrum of the wild-type protein using the web
tool DichroWeb [42,43] gave a secondary structure composition, as
presented in Table 5, which reasonably corresponded to data obtained
from the in-silico analysis of the crystal structure and showed even better
congruence, when compared to the average secondary structure compo-
sition predicted from 25 ns MD simulations of HNMT (vide infra) using
the DSC method in the YASARA suite [58]. In addition, when L208 vari-
ants were subjected to the analogous in silico analysis, no signiﬁcant dif-
ference in the content of secondary structure compared to the wild-type
was observed (Table 5).
3.7. Molecular dynamics (MD) simulations of HNMT
Using the crystal structure of HNMT in complex with SAH and hista-
mine as a starting point, 25 ns MD calculations were performed. The
structures showed over all stability over the observed time frame.
Generally, a displacement of the histamine ligand was observed. In
three of four simulations the histamine was pushed closer to the SAH
cofactor, with the deprotonated Nε2 pointing towards the sulfur atom
of SAH (Supplemental Fig. S2) and thus in a suitable orientation and dis-
tance for transfer of a methyl group. In one simulation the histamine
dissociated from the binding pocket. Analysis of this set of simulations
revealed that during all four simulations direct hydrogen bonding of
the histamine ligand to amino acid residues, which was observed in
the crystal structure, was lost in lieu of hydrogen bonds to surrounding
water molecules. Speciﬁcally, the intercalation of water molecules be-
tween N283, E28 and the aliphatic nitrogen of histamine brought the
Nε2 of histamine closer towards the SAH sulfur (Supplemental Fig. S3).Table 5
Secondary structure content of HNMT (wild-type) and L208 variants.
Secondary-structure content Wild-type (CD)c Wild-type (PDB)a Wi
Helix 38 46 40
Sheet 17 26 22
Turn 19 10 15
Coil 27 17 22
3–10 helix 1 1 ±
a The secondary structure content from the HNMT crystal structure (pdb: 1JQD:chain B).
b The average secondary structure content calculated from quadruplicate 25 ns MD simulat
c The secondary structure content of HNMT (wild-type) from the CD measurement was anaA possible explanation for the repositioning in the MD simulations, as
compared to the crystal structure lies in the distinct pH values: While
the crystals were obtained at pH 5.6, at which the protein is barely ac-
tive, MD simulations were performed at pH 7.5, where HNMT shows
maximum activity [29]. It is noteworthy that in addition to the structure
obtained at pH5.6, a SeMet structure at pH7.5was reportedwith clearly
distinct positioning of the histidine in the active site. Because this struc-
turewas not deposited in the PDB database direct comparison to our re-
sults was not possible. However, it is clear that the major repositioning
of histamine compared to the structure obtained at pH 5.6, as observed
in the SeMet counterpart, was not observed as a stable and recurrent
conformations in our simulations.
When simulations were repeated for the catalytically competent
complex of HNMT, SAM and histamine, the analogous repositioning
and ‘anchoring’ of histamine by water molecules bridging N283 and
histamine was observed in all four simulations (Fig. 7, panel A). The
positioning of the transfer-methyl group of SAM and the histamine's
acceptor atom Nε2, as seen in trajectory analyses (Fig. 7, panel B), with
distances down to ~3.2 Å approximating the van der Waals contact
distance, suggests that the MD simulation depicts the catalytically
competent enzyme complex. Furthermore, our results suggest that the
positioning of histamine in the SAM coordinated HNMT is similar as in
the SAH bound complex.
In order to gain insights into the impact of amino acid variations at
position 208, 25 ns MD simulations of the respective variants of this
study in complex with SAH and histamine were conducted. Substitu-
tions of L208 by V, F, R and K as well as the disease related L208P variant
[38] were subjected to MD analysis. The L208P variant, although appar-
ently not stable, was included in our analysis as a reference point, as it
contains an effectively helix breaking amino acid. During the 25 ns
time period of simulation all investigated structures were stable with
similar overall secondary structure content. Inspection of the average
structures revealed the presence of two principle conformations, name-
ly an open and closed conformation: the crystal structure, which was
also the principle starting structure of all simulations, showed a rather
narrow cleft between the helix spanning residues 10–25 and the helix
constituted by residues 91–105. In several simulations the distance be-
tween these two helices widened considerably (Supplemental Fig. S4).
This is consistent with previous ﬁndings that dynamic conformational
changes from closed to open forms occur in apo-HNMT [31]. Here, as a
measure of the conformational state (open versus closed), average dis-
tances of the Cα of H12 and of Cα of S91 were compiled for all MD sim-
ulations (Supplemental Table S2).
While the overall secondary structure content of the structures was
not signiﬁcantly impacted by the investigated amino acid substitutions
(Table 5), a signiﬁcant decrease of the average helical character of
helix E was found (Supplemental Table S3), suggesting destabilization
of this secondary structure. This effect was also reﬂected in a local
increase in the α-helix's RMSD values (Supplemental Table S2). Nota-
bly, the observed effects, a decrease in α-helical secondary structure
and increased RMSD values, correlated with the enzyme's activity
in vitro (Table 3 and Fig. 6), with the strongest impact on the L208R
and L208P variants. The destabilization was, however not signiﬁcantly
propagated to other secondary structure elements.ld-typeb L208 Vb L208Fb L208Rb L208Kb L208Pb
± 1 42 ± 1 42 ± 3 43 ± 3 41 ± 2 42 ± 1
± 1 24 ± 0.5 23 ± 1 24 ± 1 23 ± 1 23 ± 1
± 1 13 ± 2 12 ± 3 13 ± 1 15 ± 2 13 ± 1
± 2 19 ± 1 21 ± 2 19 ± 2 20 ± 2 22 ± 1
1 2 ± 1 2 ± 2 1 ± 1 1 ± 1 1 ± 1
ions using the YASARA suite.
lyzed using the Spectra Manager program and the web tool DichroWeb [42,43].
Fig. 7. (A) Active site of HNMT in complex with SAM and histamine showing the hydrogen bonding network (yellow), connecting the aliphatic N of histamine with the protein structure.
The 17,050 ps snapshot (snapshot #683) from one MD simulation of the HNMT:SAH:histamine complex at pH 7.5 and 310 K is shown. Nitrogen, oxygen, hydrogen and sulfur atoms are
shown in blue, red, white and green, respectively. (B) Trajectory showing the distance of the sulfur boundmethyl group of SAM and the recipient atomNε2 of histamine. The point of time
at which the snapshot from (A) was taken is indicated by a red arrow.
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the variant L208P with the histamine methylation target site Nε2
(Nε2his) more remote from the SAH sulfur than the nitrogen of the
substrate's aliphatic amino group Nhis (Table S3). In contrast, in the
wild-type the nitrogen of the aliphatic amino group remained at a
similar distance and positioning compared to the SAH sulfur in all four
simulations, whereas the reorientation of the imidazole ring away
from the SAH, resulting in a greater distance of Nε2 to the sulfur only
occurred in one instance. The variant L208F showed a similar behavior
as the variant L208P with the histamine consistently reoriented and at
greater distances than in the wild-type. In the variants L208R and
L208K deviations from average position of the histamine in the wild-
type are still observable but less pronounced. Surprisingly, the hista-
mine appears to be drawn closer to SAH in the L208K variant than in
other structures. The data are summarized in Supplemental Table S2
and average data for all four simulations are given in Table 6. Average
distances and standard deviations for a set of four MD simulations
show that SSAH - Nhis distances are strongly conserved in the wild-
type, while distances and their variations ﬂuctuate in the variants, indi-
cating that the ‘anchoring’ of histamine via its aliphatic nitrogen atom is
disturbed. This was further conﬁrmed by the visual inspection of aver-
age protein structures.
In order to assess how amino acid replacements at position 208 alter
the binding site of histamine structures obtained in our MD simulations
were analyzed in more detail. In this context, it is noteworthy that no
correlation between the open and closed conformation of HNMT and
the positioning of histaminewas observed. Visual inspection of the pro-
tein crystal structure aswell as average structures fromMD simulations
showed that S201 inα-helix E forms a hydrogen bond to S286 in the ad-
jacent β-strand, which is separated by only two amino acids from N283,
the residue apparently responsible for the correct anchoring of theTable 6
Average distances of Nε2 and aliphatic N of histamine to the sulfur of SAH (SSAH) and their










Wild-Type 8.2 2.1 9.1 0.2
L208V 8.3 1.9 10 0.2
L208F 11.4 2.2 10 1.4
L208R 8.9 2.4 10.7 1.4
L208K 7.9 3 8.7 0.8
L208P 11.5 2.6 10 1nitrogen atom of the aliphatic amino group (Fig. 8). A relative destabili-
zation and greater mobility of the α-helix in the variants, as observed
in our simulations (Supplemental Table S2 and S3), may propagate to
N283 and thus compromise histamine binding. This in turn could
reasonably rationalize the observed impaired catalytic activity of the var-
iants that correlates with the increase inα-helix destabilization. Equally,
introduction of large amino acids in position 208, e.g. phenylalanine and
arginine, leads to clasheswith Y215 (Fig. 8), which is located in the same
adjacent β-strand as S286, and may thus disturb the positioning of
histamine by N283 in a similar fashion.4. Discussion
The L208P variant of human HNMT was recently discovered as the
cause of intellectual disability although inspection of the crystal
structure did not provide a clear rationale for the putative dysfunction
of the enzyme in histamine degradation. Analysis of the impact of the
replacement of leucine by other amino acids with either charged (R, K,
H and D), polar (T, N) or apolar (V, F) side chains suggested a clear rela-
tionship disfavoring charged and polar residues in comparison to apolar
residues (Fig. 1D). This concept was borne out for the majority of vari-
ants bearing charged or polar side chains with the notable exception
of the L208 K and L208R variants. These variants could be isolated and
partially characterized although they were predicted to be less stable
than the L208T, L208H or L208N variants. This unforeseen stability of
the L208K and L208R variant could be due to the length of the side
chain that places the positively charged amino or guanidine group
closer to the surface and thus alleviates the unfavorable contacts to
the hydrophobic amino acid side chains in the vicinity of position 208.
The four variants L208V, L208F, L208K and L208R were isolated in
varying amounts. Whereas the yields for the L208V and L208F variants
were only reduced three-fold the latter two variants showed a thirty-
fold decrease (Table 1). This apparent difference in stability was also
reﬂected by the melting temperatures, which were slightly lower for
the L208F and L208V but much more severely reduced for the L208K
and L208R variants (Table 4). A similar tendency was observed in
steady-state measurements that showed slightly reduced enzymatic
activity for the L208V and L208F variants while the L208K and L208R
variants exhibited b5% residual activity (Fig. 6 and Table 3). This initial
characterization of the generated variants clearly suggested that posi-
tion 208 is very sensitive to amino acid replacements resulting in a
deterioration of stability and enzyme function, which strongly depends
on the properties of the amino acid side chain.
Fig. 8. Cartoon showing the structural features that link the residue 208 bearing α-helix, which spans residues 200–212, with residues lining the histamine binding pocket in
HNMT. Average structures from 25 ns simulations of (A) wild-type HNMT and (B) the L208R variant are shown. The histamine ligand and selected amino acids, which link the
respective secondary structures through side chain interactions are shown. Hydrogen, nitrogen and oxygen atoms are shown in white, blue and red, respectively. Carbon atoms are
shown in pink (A) and grey (B).
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which the amino acid in position 208 exerts its inﬂuence on enzymatic
activity we investigated the binding of SAM, SAH and histamine to the
variants. Interestingly, binding of SAM and SAH was apparently not
much affected in any of the variants with only a moderately higher dis-
sociation constant for SAM and SAH for the L208K and L208R variants
(Figs. 3 and 4; Table 2). In contrast, histamine binding as demonstrated
by ITC measurements (in the presence of SAH) was only detectable for
wild-type protein and even the L208V variant appeared to be compro-
mised in histamine binding (Fig. 5). This result suggests that the effect
on histamine binding is the major cause for the deterioration of enzy-
matic function in the variants. However, it was still not clear how
amino acid exchanges in position 208 affect the binding of histamine.
To address this question, we have carried out molecular dynamics
(MD) calculations on the basis of the previously reported crystal struc-
ture of the HNMT:SAH:histamine complex ( [29], PDB: 1JQD).
In ourMD simulationswe have noticed that histamine repositions in
the active site to adopt a suitable position and orientation for the trans-
fer of a methyl group from SAM to the Nε2, i.e. the crystal structure does
not reﬂect a catalytically competent complex. This difference is obvious-
ly the consequence of the different pH values used for crystallization
and our simulations, respectively. While crystallization was conducted
at a low pHwhere the enzyme is inactive, we have used a physiological
pH where the enzyme is active. Thus the observed repositioning of
histamine appears to be triggered by the difference in pH used in the
MD simulations.
Binding and positioning of histamine appears to be mainly achieved
by interactions of the aliphatic amino group with water molecules,
which are hydrogen bonding to the side chains of N283 and E28.
Although position 208 is remote from the histamine binding pocket
our simulations have indicated that amino acid exchanges destabilize
the resident α-helix and this in turn disturbs side chain interactions
with the adjacent β-strand that contains N283. Thus amino acid re-
placements in position 208 exert a long-range effect that propagates
from α-helix E to the adjacent β-strand and eventually affects amino
acids directly involved in histamine binding. This scenario is supported
by our observation that the degree of α-helix destabilization and the
loss of catalytic activity correlate. The resulting disturbance of histamine
binding can potentially impact both histamine afﬁnity (Kd) and the
correct positioning of histamine for methylation and, consequently,
the rate at which methylation occurs.
This effect from a single amino acid exchange was also observed in
another polymorphic SAM-dependent methyl transferase, thiopurine
S-methyltransferase (TPMT). The amino acid replacement of a tyrosineby a cysteine at position 240 (TPMT*3C, the Y240C variant), which is
located in β-strand 9, reduced enzymatic activity [59] and lowered the
melting temperature from 50 to 39 °C [60,61]. Although no overall
structural differences were observed in the Y240C variant, MD simula-
tions indicated a loss of side chain interactions between β-strand 9
and the adjacent helix α8, which in turn appears to affect the substrate
binding site [62]. Another SAM-dependent transferase, catechol
O-methyltransferase (COMT), exhibits a similar structural alteration in
the V108M variant. Again, this position is ~16 Å apart from the SAM-
binding site, but the amino acid exchange causes the reorientation of a
proximal helix, resulting in the perturbation of the SAM and substrate
binding sites [63,64].
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